HomeClinical TopicsFDA approves first generic versions of Boniva

FDA approves first generic versions of Boniva

On March 19, the U.S. Food and Drug Administration (FDA) approved the first generic versions of Boniva (ibandronate) tablets, used to treat osteoporosis. Read more

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content